A man with atypical hemolytic uremic syndrome (aHUS) who had received a kidney transplant later developed a recurrence of the…
Articles by Patricia Inácio, PhD
A woman with treatment-resistant lupus nephritis — the most common kidney…
People with atypical hemolytic uremic syndrome (aHUS) who’ve had a kidney transplant can safely switch from Soliris (eculizumab) to …
People with atypical hemolytic uremic syndrome (aHUS) who stop taking Soliris (eculizumab) have a 16.5% higher risk of…
Atypical hemolytic uremic syndrome (aHUS) can occur as a rare complication of surgery involving the urinary tract, according to…
Timely diagnosis and aggressive treatment were crucial for the recovery of a 26-year-old woman who was diagnosed with atypical…
COVID-19 triggered atypical hemolytic uremic syndrome (aHUS) in a 13-year-old boy with a genetic predisposition to the syndrome, a…
Under a new commercialization agreement with Samsung Bioepis, the developer of Epysqli (eculizumab-aagh), Teva Pharmaceuticals will have exclusive marketing…
Physicians in India described the case of atypical hemolytic uremic syndrome (aHUS) that manifested as loss of vision in…
Mutations in the Wilms’ tumor 1 (WT1) gene, known to cause a rare kidney disorder called Denys-Drash syndrome, were found…